Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Die Folgen des Klimwandels haben einen direkten Einfluss auf die Primärversorgung in Deutschland: Hitzeschutz insbesondere bei älteren Patienten, die Zunahme von Infektionen und die Verlängerung der Allergiesesaison spielen medizinisch eine bedeutsame Rolle. Aber auch in der Prävention und der Aufklärung der Patienten kommt den Hausärztinnen und -ärzten eine besondere Rolle zu. Direkt aus der Praxis berichtet im Live-Webinar am 13. Mai von 18 bis 19 Uhr unser Experte Dr. med. Robin Maitra.
Erweiterte Suche
Anmelden
nach oben
Current Cardiology Reports
Erschienen in: Current Cardiology Reports 11/2017

01.11.2017 | Psychological Aspects of Cardiovascular Diseases (A Steptoe, Section Editor)

Improving Medication Adherence in Coronary Heart Disease

verfasst von: Leah L. Zullig, Katherine Ramos, Hayden B. Bosworth

Erschienen in: Current Cardiology Reports | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The purpose of this review was to synthesize research findings from recently published randomized controlled trials (RCTs) targeting any phase of medication adherence, from initiation to discontinuation, among patients with coronary heart disease (CHD).

Recent Findings

We identified successful strategies and promising practices for improving medication adherence among patients diagnosed with CHD. Consistent intervention strategies included the following: (1) facilitating patient-provider communication, (2) using mHealth technologies with emphasis on two-way communication, (3) providing patient education in tandem with lifestyle and behavioral counseling, and (4) providing psychosocial support. Regarding medication adherence phases, all studies examined implementation (i.e., taking medications as prescribed over time) and one also addressed treatment initiation (i.e., beginning a new medication). None identified addressed discontinuation. Studies varied by use of objective, self-report, and a combination of outcome measures with a greater number reporting only subjective measures of adherence. Key findings remained mixed in supporting specific intervention designs or delivery formats.

Summary

This review addresses available data of promising practices for improving CHD medication adherence. Future studies are needed to examine intervention effectiveness, scalability, and durability of observed outcome effects.
Literatur
1.
Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
2.
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke Statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–603.PubMedPubMedCentralCrossRef
3.
World Health Organization. Preventing chronic diseases: a vital investment. Geneva: World Health Organization; 2005.
4.
Bitton A, Choudhry NK, Matlin OS, Swanton K, Shrank WH. The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review. Am J Med. 2013;126(4):357.e7-.e27.CrossRef
5.
Dunbar-Jacob J, Bohachick P, Mortimer MK, Sereika SM, Foley SM. Medication adherence in persons with cardiovascular disease. J Cardiovasc Nurs. 2003;18(3):209–18.PubMedCrossRef
6.
Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772–9.PubMedCrossRef
7.
Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028–35.PubMedCrossRef
8.
Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.PubMedPubMedCentralCrossRef
9.
Roth GA, Morden NE, Zhou W, Malenka DJ, Skinner J. Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent. Circ Cardiovasc Qual Outcomes. 2012;5(1):103–12.PubMedCrossRef
10.
Mann DM, Allegrante JP, Natarajan S, Halm EA, Charlson M. Predictors of adherence to statins for primary prevention. Cardiovasc Drugs Ther. 2007;21(4):311–6.PubMedCrossRef
11.
Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166(17):1842–7.PubMedCrossRef
12.
Kramer JM, Hammill B, Anstrom KJ, Fetterolf D, Snyder R, Charde JP, et al. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. Am Heart J. 2006;152(3):454.e1-8.PubMedCrossRef
13.
Melnikow J, Kiefe C. Patient compliance and medical research: issues in methodology. J Gen Intern Med. 1994;9(2):96–105.PubMedCrossRef
14.
Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9(1):11–23.PubMedPubMedCentralCrossRef
15.
Schmittdiel JA, Nichols GA, Dyer W, Steiner JF, Karter AJ, Raebel MA. Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Med Care. 2015;53(4):332–7.PubMedPubMedCentral
16.
Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73(6):545–62.PubMedPubMedCentralCrossRef
17.
Mistry N, Keepanasseril A, Wilczynski NL, Nieuwlaat R, Ravall M, Haynes RB. Technology-mediated interventions for enhancing medication adherence. J Am Med Inform Assoc: JAMIA. 2015;22(e1):e177–93.PubMedCrossRef
18.
•• Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014(11) https://​doi.​org/​10.​1002/​14651858. This study reports findings from a sysetmatic review to assess the effects of interventions thtat improve both medication adherence and relevant clinical outcomes.
19.
•• van Driel ML, Morledge MD, Ulep R, Shaffer JP, Davies P, Deichmann R. Interventions to improve adherence to lipid-lowering medication. Cochrane Database Syst Rev. 2016;12:Cd004371. This study reports findings from a systematic review to assess the effects of interventions aimed at improving adherence to lipid-lowering medications and associated clinical outcomes.PubMed
20.
Al-Foraih M, Somerset S. Factors affecting adherence to statins in Hypercholesterolemic Kuwaiti patients: a cross-sectional study. Med Princ Pract: Int J Kuwait Univ, Health Sci Cent. 2017;26(1):35–40.CrossRef
21.
Alsabbagh MW, Lix LM, Eurich D, Wilson TW, Blackburn DF. Multiple-domain versus single-domain measurements of socioeconomic status (SES) for predicting nonadherence to statin medications: an observational population-based cohort study. Med Care. 2016;54(2):195–204.PubMedCrossRef
22.
Ammenwerth E, Woess S, Baumgartner C, Fetz B, van der Heidt A, Kastner P, et al. Evaluation of an integrated Telemonitoring surveillance system in patients with coronary heart disease. Methods Inf Med. 2015;54(5):388–97.PubMedCrossRef
23.
Aspry KE, Furman R, Karalis DG, Jacobson TA, Zhang AM, Liptak GS, et al. Effect of health information technology interventions on lipid management in clinical practice: a systematic review of randomized controlled trials. J Clin Lipidol. 2013;7(6):546–60.PubMedCrossRef
24.
Ayala C, Fang J, Yuan K. Prevalence of taking actions to control blood pressure among adults with self-reported hypertension in 18 states and the District of Columbia, 2009. J Clin Hypertens (Greenwich, Conn). 2015;17(3):172–82.CrossRef
25.
Banerjee A, Khandelwal S, Nambiar L, Saxena M, Peck V, Moniruzzaman M, et al. Health system barriers and facilitators to medication adherence for the secondary prevention of cardiovascular disease: a systematic review. Open Heart. 2016;3(2):e000438.PubMedPubMedCentralCrossRef
26.
Barker-Collo S, Krishnamurthi R, Witt E, Feigin V, Jones A, McPherson K, et al. Improving adherence to secondary stroke prevention strategies through motivational interviewing: randomized controlled trial. Stroke. 2015;46(12):3451–8.PubMedCrossRef
27.
Berkowitz SA, Seligman HK, Choudhry NK. Treat or eat: food insecurity, cost-related medication underuse, and unmet needs. Am J Med. 2014;127(4):303-10.e3.CrossRef
28.
Cai H, Dai H, Hu Y, Yan X, Xu H. Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials. BMC Health Serv Res. 2013;13:461.PubMedPubMedCentralCrossRef
29.
Campbell DJ, Tonelli M, Hemmelgarn B, Mitchell C, Tsuyuki R, Ivers N, et al. Assessing outcomes of enhanced chronic disease care through patient education and a value-based formulary study (ACCESS)-study protocol for a 2x2 factorial randomized trial. Implement Sci: IS. 2016;11(1):131.PubMedPubMedCentralCrossRef
30.
Cao XY, Tian L, Chen L, Jiang XL. Effects of a hospital-community partnership transitional program in patients with coronary heart disease in Chengdu, China: A randomized controlled trial. Jpn J Nurs Sci: JJNS. 2017 https://​doi.​org/​10.​1111/​jjns.​12160.
31.
Chatelin J, Stathopoulou MG, Arguinano AA, Xie T, Visvikis-Siest S. Pharmacogenomic challenges in cardiovascular diseases: examples of drugs and considerations for future integration in clinical practice. Curr Pharm Biotechnol 2017;18(3):231–41.
32.
Chen S, Gong E, Kazi DS, Gates AB, Karaye KM, Girerd N, et al. Development of a mobile phone-based intervention to improve adherence to secondary prevention of coronary heart disease in China. J Med Eng Technol. 2016;40(7–8):372–82.PubMedCrossRef
33.
Cheng HM, Chiang CE, Chen CH. The novelty of the 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan hypertension Society for the Management of hypertension. Pulse (Basel, Switzerland). 2015;3(1):29–34.
34.
Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940–8.PubMedCrossRef
35.
Dale LP, Whittaker R, Jiang Y, Stewart R, Rolleston A, Maddison R. Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials. 2014;15:71.PubMedPubMedCentralCrossRef
36.
Davies AK, McGale N, Humphries SE, Hirani SP, Beaney KE, Bappa DA, et al. Effectiveness of a self-management intervention with personalised genetic and lifestyle-related risk information on coronary heart disease and diabetes-related risk in type 2 diabetes (CoRDia): study protocol for a randomised controlled trial. Trials. 2015;16:547.PubMedPubMedCentralCrossRef
37.
38.
Everett B, Salamonson Y, Rolley JX, Davidson PM. Underestimation of risk perception in patients at risk of heart disease. Eur J Cardiovasc Nurs: J Work Group Cardiovasc Nurs Eur Soc Cardiol. 2016;15(3):e2–9.CrossRef
39.
Fang R, Li X. Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. J Clin Nurs. 2016;25(5–6):664–71.PubMedCrossRef
40.
Gaisenok O, Martsevich S, Tripkosh S, Lukina Y. Analysis of lipid-lowering therapy and factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry. Rev Port Cardiol: Orgao Oficial Soc Port Cardiol = Port J Cardiol: Off J Port Soc Cardiol. 2015;34(2):111–6.
41.
Galema-Boers JM, Lenzen MJ, van Domburg RT, Roeters van Lennep J, van Bruchem-van de Scheur GG, Sijbrands EJ, et al. Predicting non-adherence in patients with familial hypercholesterolemia. Eur J Clin Pharmacol. 2014;70(4):391–7.PubMedCrossRef
42.
Goss F, Brachmann J, Hamm CW, Haerer W, Reifart N, Levenson B. High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor study. Vasc Health Risk Manag. 2017;13:127–37.PubMedPubMedCentralCrossRef
43.
Gu D, He J, Coxson PG, Rasmussen PW, Huang C, Thanataveerat A, et al. The cost-effectiveness of low-cost essential antihypertensive medicines for hypertension control in China: a modelling study. PLoS Med. 2015;12(8):e1001860.PubMedPubMedCentralCrossRef
44.
Gunnell AS, Knuiman MW, Geelhoed E, Hobbs MS, Katzenellenbogen JM, Hung J, et al. Long-term use and cost-effectiveness of secondary prevention drugs for heart disease in western Australian seniors (WAMACH): a study protocol. BMJ Open. 2014;4(9):e006258.PubMedPubMedCentralCrossRef
45.
Irvin MR, Shimbo D, Mann DM, Reynolds K, Krousel-Wood M, Limdi NA, et al. Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension. J Clin Hypertens (Greenwich, Conn). 2012;14(10):694–700.CrossRef
46.
Kalia NK, Cespedes L, Youssef G, Li D, Budoff MJ. Motivational effects of coronary artery calcium scores on statin adherence and weight loss. Coron Artery Dis. 2015;26(3):225–30.PubMedCrossRef
47.
Kamath DY, Xavier D, Gupta R, Devereaux PJ, Sigamani A, Hussain T, et al. Rationale and design of a randomized controlled trial evaluating community health worker-based interventions for the secondary prevention of acute coronary syndromes in India (SPREAD). Am Heart J. 2014;168(5):690–7.PubMedPubMedCentralCrossRef
48.
49.
Keyserling TC, Sheridan SL, Draeger LB, Finkelstein EA, Gizlice Z, Kruger E, et al. A comparison of live counseling with a web-based lifestyle and medication intervention to reduce coronary heart disease risk: a randomized clinical trial. JAMA Intern Med. 2014;174(7):1144–57.PubMedPubMedCentralCrossRef
50.
Kim HY, Lee JA, Kim YS, Sunwoo S, Oh HJ, Kim CS, et al. Factors of compliance in patients with hypercholesterolemia using rosuvastatin in primary care. Korean J Fam Med. 2012;33(5):253–61.PubMedPubMedCentralCrossRef
51.
Kim S, Shin DW, Yun JM, Hwang Y, Park SK, Ko YJ, et al. Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension (Dallas, Tex : 1979). 2016;67(3):506–12.
52.
Kreibig SD, Whooley MA, Gross JJ. Social integration and mortality in patients with coronary heart disease: findings from the heart and soul study. Psychosom Med. 2014;76(8):659–68.PubMedPubMedCentralCrossRef
53.
Kripalani S, Schmotzer B, Jacobson TA. Improving medication adherence through graphically enhanced interventions in coronary heart disease (IMAGE-CHD): a randomized controlled trial. J Gen Intern Med. 2012;27(12):1609–17.PubMedPubMedCentralCrossRef
54.
Kronish IM, Lynch AI, Oparil S, Whittle J, Davis BR, Simpson LM, et al. The association between antihypertensive medication nonadherence and visit-to-visit variability of blood pressure: findings from the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension (Dallas, Tex : 1979). 2016;68(1):39–45.CrossRef
55.
Kunutsor SK, Seidu S, Khunti K. Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials. Diabet Med: J Br Diabet Assoc. 2017;34(3):316–27.CrossRef
56.
Lee WL, Abdullah KL, Bulgiba AM, Zainal AI. Prevalence and predictors of patient adherence to health recommendations after acute coronary syndrome: data for targeted interventions? Eur J Cardiovasc Nurs: J Work Group Cardiovasc Nurs Eur Soc Cardiol. 2013;12(6):512–20.CrossRef
57.
58.
Librero J, Sanfelix-Gimeno G, Peiro S. Medication adherence patterns after hospitalization for coronary heart disease. A population-based study using electronic records and group-based trajectory models. PLoS One. 2016;11(8):e0161381.PubMedPubMedCentralCrossRef
59.
Lin EH, Von Korff M, Ciechanowski P, Peterson D, Ludman EJ, Rutter CM, et al. Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial. Ann Fam Med. 2012;10(1):6–14.PubMedPubMedCentralCrossRef
60.
Ludt S, Wensing M, Campbell SM, Ose D, van Lieshout J, Rochon J, et al. The challenge of cardiovascular prevention in primary care: implications of a European observational study in 8928 patients at different risk levels. Eur J Prev Cardiol. 2014;21(2):203–13.PubMedCrossRef
61.
Malik S, Billimek J, Greenfield S, Sorkin DH, Ngo-Metzger Q, Kaplan SH. Patient complexity and risk factor control among multimorbid patients with type 2 diabetes: results from the R2D2C2 study. Med Care. 2013;51(2):180–5.PubMedPubMedCentralCrossRef
62.
Marcum ZA, Zheng Y, Perera S, Strotmeyer E, Newman AB, Simonsick EM, et al. Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension. Res Social Adm Pharm: RSAP. 2013;9(6):817–27.PubMedCrossRef
63.
Martin SS, Sperling LS, Blaha MJ, Wilson PW, Gluckman TJ, Blumenthal RS, et al. Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA guidelines. J Am Coll Cardiol. 2015;65(13):1361–8.PubMedPubMedCentralCrossRef
64.
Meng K, Seekatz B, Haug G, Mosler G, Schwaab B, Worringen U, et al. Evaluation of a standardized patient education program for inpatient cardiac rehabilitation: impact on illness knowledge and self-management behaviors up to 1 year. Health Educ Res. 2014;29(2):235–46.PubMedCrossRef
65.
Mertens A, Brandl C, Miron-Shatz T, Schlick C, Neumann T, Kribben A, et al. A mobile application improves therapy-adherence rates in elderly patients undergoing rehabilitation: a crossover design study comparing documentation via iPad with paper-based control. Medicine. 2016;95(36):e4446.PubMedPubMedCentralCrossRef
66.
Moise N, Khodneva Y, Richman J, Shimbo D, Kronish I, Safford MM. Elucidating the Association Between Depressive Symptoms, Coronary Heart Disease, and Stroke in Black and White Adults: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. J Am Heart Assoc. 2016;5(8):e003767.PubMedPubMedCentralCrossRef
67.
Molloy GJ, Messerli-Burgy N, Hutton G, Wikman A, Perkins-Porras L, Steptoe A. Intentional and unintentional non-adherence to medications following an acute coronary syndrome: a longitudinal study. J Psychosom Res. 2014;76(5):430–2.PubMedPubMedCentralCrossRef
68.
Molloy GJ, Randall G, Wikman A, Perkins-Porras L, Messerli-Burgy N, Steptoe A. Type D personality, self-efficacy, and medication adherence following an acute coronary syndrome. Psychosom Med. 2012;74(1):100–6.PubMedCrossRef
69.
Mosleh SM, Almalik MM. Illness perception and adherence to healthy behaviour in Jordanian coronary heart disease patients. Eur J Cardiovasc Nurs: J Work Group Cardiovasc Nurs Eur Soc Cardiol. 2016;15(4):223–30.CrossRef
70.
Mosleh SM, Darawad M. Patients' Adherence to healthy behavior in coronary heart disease: risk factor management among Jordanian patients. J Cardiovasc Nurs. 2015;30(6):471–8.PubMedCrossRef
71.
Muntner P, Yun H, Sharma P, Delzell E, Kent ST, Kilgore ML, et al. Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event. Am J Cardiol. 2014;114(6):826–31.PubMedCrossRef
72.
Nord JW Jr, Berry A, Stults B, Burningham Z, Beddhu S. Evaluation of the effectiveness of a patient-centered educational mailer designed to improve statin adherence: a pragmatic trial. EGEMS (Washington, DC). 2016;4(1):1256.
73.
Ose D, Rochon J, Campbell SM, Wensing M, van Lieshout J, Uhlmann L, et al. Secondary prevention in patients with coronary heart diseases: what factors are associated with health status in usual primary care? PLoS One. 2012;7(12):e51726.PubMedPubMedCentralCrossRef
74.
Park LG, Howie-Esquivel J, Chung ML, Dracup K. A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Educ Couns. 2014;94(2):261–8.PubMedCrossRef
75.
Park LG, Howie-Esquivel J, Whooley MA, Dracup K. Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. Eur J Cardiovasc Nurs: J Work Group Cardiovasc Nurs Eur Soc Cardiol. 2015;14(3):264–73.CrossRef
76.
Pedrosa RB, Rodrigues RC. Adaptation and evaluation of the measurement properties of the Brazilian version of the self-efficacy for appropriate medication adherence scale. Rev Lat Am Enfermagem. 2016;24:e2692.PubMedPubMedCentralCrossRef
77.
Pfaeffli Dale L, Whittaker R, Jiang Y, Stewart R, Rolleston A, Maddison R. Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. J Med Internet Res. 2015;17(10):e237.PubMedPubMedCentralCrossRef
78.
Pousinho S, Morgado M, Falcao A, Alves G. Pharmacist interventions in the Management of Type 2 diabetes mellitus: a systematic review of randomized controlled trials. J Manag Care Spec Pharm. 2016;22(5):493–515.PubMedCrossRef
79.
Sallis R, Franklin B, Joy L, Ross R, Sabgir D, Stone J. Strategies for promoting physical activity in clinical practice. Prog Cardiovasc Dis. 2015;57(4):375–86.PubMedCrossRef
80.
Santo K, Kirkendall S, Laba TL, Thakkar J, Webster R, Chalmers J, et al. Interventions to improve medication adherence in coronary disease patients: a systematic review and meta-analysis of randomised controlled trials. Eur J Prev Cardiol. 2016;23(10):1065–76.PubMedCrossRef
81.
Schneider KI, Schmidtke J. Patient compliance based on genetic medicine: a literature review. J Community Genet. 2014;5(1):31–48.PubMedCrossRef
82.
Simpson RJ Jr, Tunceli K, Ramey DR, Neff DR, Kern DM, Hsieh HM, et al. Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting. J Clin Lipidol. 2013;7(5):399–407.PubMedCrossRef
83.
Sin NL, Kumar AD, Gehi AK, Whooley MA. Direction of association between depressive symptoms and lifestyle behaviors in patients with coronary heart disease: the heart and soul study. Ann Behav Med: Publ Soc Behav Med. 2016;50(4):523–32.CrossRef
84.
Sin NL, Moskowitz JT, Whooley MA. Positive affect and health behaviors across 5 years in patients with coronary heart disease: the heart and soul study. Psychosom Med. 2015;77(9):1058–66.PubMedPubMedCentralCrossRef
85.
Son YJ, Shim SK, Hwang SY, Ahn JH, Yu HY. Impact of left ventricular ejection fraction and medication adherence on major adverse cardiac events during the first year after successful primary percutaneous coronary interventions. J Clin Nurs. 2016;25(7–8):1101–11.PubMedCrossRef
86.
Stamm-Balderjahn S, Brunger M, Michel A, Bongarth C, Spyra K. The efficacy of goal setting in cardiac rehabilitation-a gender-specific randomized controlled trial. Dtsch Arztebl Int. 2016;113(31–32):525–31.PubMedPubMedCentral
87.
Tsoi KK, Wong MC, Tam WW, Hirai HW, Lao XQ, Wang HH, et al. Cardiovascular mortality in hypertensive patients newly prescribed perindopril vs. lisinopril: a 5-year cohort study of 15,622 Chinese subjects. Int J Cardiol. 2014;176(3):703–9.PubMedCrossRef
88.
Varghese T, Schultz WM, McCue AA, Lambert CT, Sandesara PB, Eapen DJ, et al. Physical activity in the prevention of coronary heart disease: implications for the clinician. Heart. 2016;102(12):904–9.PubMedCrossRef
89.
Vorderstrasse AA, Ginsburg GS, Kraus WE, Maldonado MC, Wolever RQ. Health coaching and genomics-potential avenues to elicit behavior change in those at risk for chronic disease: protocol for personalized medicine effectiveness study in air force primary care. Glob Adv Health Med. 2013;2(3):26–38.PubMedPubMedCentralCrossRef
90.
Wald DS, Bestwick JP, Raiman L, Brendell R, Wald NJ. Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial). PLoS One. 2014;9(12):e114268.PubMedPubMedCentralCrossRef
91.
Wong MC, Tam WW, Cheung CS, Wang HH, Tong EL, Sek AC, et al. Drug adherence and the incidence of coronary heart disease- and stroke-specific mortality among 218,047 patients newly prescribed an antihypertensive medication: a five-year cohort study. Int J Cardiol. 2013;168(2):928–33.PubMedCrossRef
92.
Yang EY, Chambless L, Sharrett AR, Virani SS, Liu X, Tang Z, et al. Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the atherosclerosis risk in communities (ARIC) study. Stroke. 2012;43(1):103–8.PubMedCrossRef
93.
Yudi MB, Clark DJ, Tsang D, Jelinek M, Kalten K, Joshi S, et al. SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes [SMART-REHAB trial]: a randomized controlled trial protocol. BMC Cardiovasc Disord. 2016;16(1):170.PubMedPubMedCentralCrossRef
94.
Zhao S, Zhao H, Wang L, Du S, Qin Y. Education is critical for medication adherence in patients with coronary heart disease. Acta Cardiol. 2015;70(2):197–204.PubMedCrossRef
95.
Zhao SJ, Zhao HW, Du S, Qin YH. The impact of clinical pharmacist support on patients receiving multi-drug therapy for coronary heart disease in China. Indian J Pharm Sci. 2015;77(3):306–11.PubMedPubMedCentralCrossRef
96.
Zhu L, Xu J, Wang Q, Xu F, Chen J. Nursing care of transradial angiography and intervention in a tertiary hospital in shanghai: a best practice implementation project. JBI Database Syst Rev Implement Rep. 2016;14(5):286–94.CrossRef
97.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.PubMedCrossRef
98.
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich, Conn). 2008;10(5):348–54.CrossRef
99.
Jank S, Bertsche T, Schellberg D, Herzog W, Haefeli WE. The A14-scale: development and evaluation of a questionnaire for assessment of adherence and individual barriers. Pharm World Sci: PWS. 2009;31(4):426–31.PubMedCrossRef
100.
Riddle MC, Rosenstock J, Gerich J. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26(11):3080–6.PubMedCrossRef
101.
Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105–16.PubMedCrossRef
102.
• Zullig LL, Mendys P, Bosworth HB. Medication adherence: a practical measurement selection guide using case studies. Patient Educ Couns. 2017;100(7):1410–4. This paper uses case studies to provide examples of selecting the appropraite medication adherence measures.PubMedCrossRef
103.
104.
Sheridan SL, Draeger LB, Pignone MP, Sloane PD, Samuel-Hodge C, Finkelstein EA, et al. Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for the heart to health study. Contemp Clin Trials. 2013;36(2):394–405.PubMedPubMedCentralCrossRef
105.
Adler AJ, Martin N, Mariani J, Tajer CD, Owolabi OO, Free C, et al. Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2017;4:Cd011851.PubMed
106.
de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev. 2012;12:Cd007459.PubMed
107.
DeKoekkoek T, Given B, Given CW, Ridenour K, Schueller M, Spoelstra SL. mHealth SMS text messaging interventions and to promote medication adherence: an integrative review. J Clin Nurs. 2015;24(19–20):2722–35.PubMedCrossRef
108.
Cutrona SL, Choudhry NK, Fischer MA, Servi A, Liberman JN, Brennan TA, et al. Modes of delivery for interventions to improve cardiovascular medication adherence. Am J Manag Care. 2010;16(12):929–42.PubMedPubMedCentral
109.
Teeter BS, Kavookjian J. Telephone-based motivational interviewing for medication adherence: a systematic review. Transl Behav Med. 2014;4(4):372–81.PubMedPubMedCentralCrossRef
110.
Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167(6):540–50.PubMedCrossRef
111.
112.
Glanz K, Rimer BK, Viswanath K. Health behavior and health education: theory, research, and practice. Hoboken: John Wiley & Sons; 2008.
113.
Snyderman R. Personalized health care: from theory to practice. Biotechnol J. 2012;7(8):973–9.PubMedCrossRef
114.
Metadaten
Titel
Improving Medication Adherence in Coronary Heart Disease
verfasst von
Leah L. Zullig
Katherine Ramos
Hayden B. Bosworth
Publikationsdatum
01.11.2017
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 11/2017
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-017-0918-y

Weitere Artikel der Ausgabe 11/2017

Current Cardiology Reports 11/2017 Zur Ausgabe

Valvular Heart Disease (T Kiefer, Section Editor)

Evolving Indications for Transcatheter Aortic Valve Interventions

Psychological Aspects of Cardiovascular Diseases (A Steptoe, Section Editor)

Socioeconomic Status and Cardiovascular Disease: an Update

Valvular Heart Disease (T Kiefer, Section Editor)

Current Treatment Strategies for Tricuspid Regurgitation

Public Health Policy (E Klodas, Section Editor)

Lifestyle Medicine and the Management of Cardiovascular Disease

Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate

Psychological Aspects of Cardiovascular Diseases (A Steptoe, Section Editor)

Sleep and Cardio-Metabolic Disease

Neu im Fachgebiet Kardiologie

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

10.05.2024 Periphere arterielle Verschlusskrankheit Nachrichten

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise